Cargando…

Evaluating ZNF217 mRNA Expression Levels as a Predictor of Response to Endocrine Therapy in ER+ Breast Cancer

ZNF217 is a candidate oncogene with a wide variety of deleterious functions in breast cancer. Here, we aimed at investigating in a pilot prospective study the association between ZNF217 mRNA expression levels and the clinical response to neoadjuvant endocrine therapy (ET) in postmenopausal ER-positi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vendrell, Julie A., Solassol, Jérôme, Győrffy, Balázs, Vilquin, Paul, Jarlier, Marta, Donini, Caterina F., Gamba, Laurent, Maudelonde, Thierry, Rouanet, Philippe, Cohen, Pascale A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355665/ https://www.ncbi.nlm.nih.gov/pubmed/30740056 http://dx.doi.org/10.3389/fphar.2018.01581

Ejemplares similares

Exploring the Significance of the Exon 4-Skipping Isoform of the ZNF217 Oncogene in Breast Cancer
por: Bellanger, Aurélie, et al.
Publicado: (2021)

The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value
por: Cohen, Pascale A., et al.
Publicado: (2015)

The ZNF217 Biomarker Predicts Low- and High-Risk Oncotype DX(®) Recurrence Score in ER-Positive Invasive Breast Cancers
por: Cohen, Pascale A., et al.
Publicado: (2019)

ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells
por: Thollet, Aurélie, et al.
Publicado: (2010)

The Intricate Interplay between the ZNF217 Oncogene and Epigenetic Processes Shapes Tumor Progression
por: Fahmé, Pia, et al.
Publicado: (2022)

Comparative Methods to Improve the Detection of BRAF V600 Mutations in Highly Pigmented Melanoma Specimens
por: Frouin, Eric, et al.
Publicado: (2016)

Proteomic profile determination of autosomal aneuploidies by mass spectrometry on amniotic fluids
por: Mange, Alain, et al.
Publicado: (2008)

MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer
por: Vilquin, Paul, et al.
Publicado: (2015)

MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity
por: Li, Zewu, et al.
Publicado: (2015)

Retraction: MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity
Publicado: (2020)

Conditional Probability of Survival and Prognostic Factors in Long-Term Survivors of High-Grade Serous Ovarian Cancer
por: Fabbro, Michel, et al.
Publicado: (2020)

Autoantibody signatures: progress and perspectives for early cancer detection
por: Desmetz, C, et al.
Publicado: (2011)

Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha
por: Frietze, Seth, et al.
Publicado: (2014)

Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress
por: Jiang, Xingkang, et al.
Publicado: (2016)

Zinc finger gene 217 (ZNF217) Promoted Ovarian Hyperstimulation Syndrome (OHSS) through Regulating E(2) Synthesis and Inhibiting Thrombospondin-1 (TSP-1)
por: Zhai, Junyu, et al.
Publicado: (2017)

Comparison of Supervised Classification Methods for Protein Profiling in Cancer Diagnosis
por: Dossat, Nadège, et al.
Publicado: (2007)

HDL Proteome in Hemodialysis Patients: A Quantitative Nanoflow Liquid Chromatography-Tandem Mass Spectrometry Approach
por: Mangé, Alain, et al.
Publicado: (2012)

KRAS Mutation Detection in Paired Frozen and Formalin-Fixed Paraffin-Embedded (FFPE) Colorectal Cancer Tissues
por: Solassol, Jérome, et al.
Publicado: (2011)

Oncogenic protein SALL4 and ZNF217 as prognostic indicators in solid cancers: a meta-analysis of individual studies
por: Cheng, Ji, et al.
Publicado: (2016)

OIP5-AS1/miR-137/ZNF217 Axis Promotes Malignant Behaviors in Epithelial Ovarian Cancer
por: Guo, Linlin, et al.
Publicado: (2020)

Retracted Article: Berberine alleviates amyloid beta-induced injury in Alzheimer's disease by miR-107/ZNF217
por: Wang, Jing, et al.
Publicado: (2019)

EGFR-dependent mechanisms of resistance to osimertinib determined by ctDNA NGS analysis identify patients with better outcome
por: Vendrell, Julie A., et al.
Publicado: (2021)

The PCOS GWAS Candidate Gene ZNF217 Influences Theca Cell Expression of DENND1A.V2, CYP17A1, and Androgen Production
por: Waterbury, Jamaia S, et al.
Publicado: (2022)

LncRNA MALAT1 promotes wound healing via regulating miR-141-3p/ZNF217 axis
por: Liang, Zun-Hong, et al.
Publicado: (2020)

Effect of a Bone Morphogenetic Protein-2-derived peptide on the expression of tumor marker ZNF217 in osteoblasts and MCF-7 cells
por: Mantsou, Aglaia, et al.
Publicado: (2021)

CircCSNK1G1 Contributes to the Tumorigenesis of Gastric Cancer by Sponging miR-758 and Regulating ZNF217 Expression
por: Qiang, Feng, et al.
Publicado: (2021)

Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphoma
por: Briest, Franziska, et al.
Publicado: (2023)

OR34-2 SREBP1 Drives KRT80-Dependent Cytoskeletal Changes and Invasive Behaviour in Endocrine-Resistant ERα Breast Cancer
por: Perone, Ylenia, et al.
Publicado: (2019)

Combination of tissue and liquid biopsy molecular profiling to detect transformation to small cell lung carcinoma during osimertinib treatment
por: Vendrell, Julie A., et al.
Publicado: (2020)

Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells
por: Zhang, Chuanzhao, et al.
Publicado: (2016)

ZNF213 Facilitates ER Alpha Signaling in Breast Cancer Cells
por: Yang, Huijie, et al.
Publicado: (2021)

Pemphigus vulgaris antigen mRNA quantification for the staging of sentinel lymph nodes in head and neck cancer
por: Solassol, J, et al.
Publicado: (2010)

Knockdown of lncRNA-ATB suppresses autocrine secretion of TGF-β2 by targeting ZNF217 via miR-200c in keloid fibroblasts
por: Zhu, Hua-Yu, et al.
Publicado: (2016)

Long non-coding RNA CTBP1-AS2 enhances cervical cancer progression via up-regulation of ZNF217 through sponging miR-3163
por: Yang, Shanshan, et al.
Publicado: (2020)

Memorandum: I217 update
por: CERN. Geneva. SPS-PS Experiments Committee
Publicado: (1999)

Health Tract, No. 217: Hunger
Publicado: (1865)

Health Tract, No. 217: Hunger
Publicado: (1864)

Clinics in diagnostic imaging (217)
por: Ong, Wu Lin Low, et al.
Publicado: (2023)

SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer
por: Perone, Ylenia, et al.
Publicado: (2019)

Integrated MicroRNA–mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer
por: Bottai, Giulia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q45uunsu6cueapj6vkdhqgcv7u